The Prescription Pattern and Analyses of Antidepressants under the National Health Insurance Policy in Taiwan

健保制度下抗憂鬱劑的世代分析及處方行為

10.29478/TJP.201106.0003

黃崇恆(Chong-Heng Huang)；陳繼明(Chi-Ming Chen)；許光陽(Kuang-Yang Hsu)；陳麗珍(Lih-Jen C Wang)；陳世英(Shih-Ying Chen)；李靜芬(Ching-Fen Lee)

Antidepressants ； National Health Insurance Research Database ； drug generation substitution ； drug generation competition

台灣精神醫學

25卷2期（2011 / 06 / 01）

76 - 85

英文

Background: In this study, we examined trends associated with various antidepressants competing in the Taiwanese market, based on data from the National Health Insurance (NHI) Research Database. Methods: The cases of patients diagnosed with depression were selected as the subjects of this study. The prescription and use of antidepressants were analyzed to shed light on the competition in the market and substitution of these drugs, as influenced by the NHI insurance system. Results: The data indicated that the number of patients diagnosed with clinical depression was increased twofold and that the associated expenditure on antidepressants was increased threefold between 1997 and 2004. We also observed the total incremental use of antidepressants in each category, indicating that third-generation antidepressants continued to dominate market, and gradually replaced those of the first-generation antidepressants. The use of second-generation antidepressants was found to have remained relatively unchanged. Among all levels of hospital organizations, third-generation antidepressants were found to be preferred. The medical staff at district hospitals and primary care clinics prescribed more first-generation antidepressants than those at regional hospitals or medical centers. Conclusions: The use of third-generation antidepressants has surpassed that of first-and second-generation. The non-free market drug reimbursement mechanism governed by NHI had influence on prescription patterns of antidepressants in hospitals. All aspects of competition among antidepressants are in line with the Porter's theory of competition.

1. (2007).Drug Topic of Red Book, 2000-2006.Montvale New Jersey:Thomson Healthcare.
2. American Psychiatric Association(2000).Diagnostic and Statistical Manual of Mental Disorders.Washington DC:American Psychiatric Association.
3. Anderson, IM(2000).Selectine serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.J Affect Disord,58,19-36.
4. Cheng, TM(2003).Taiwan's new national health insurance program: genesis and experience so far.Health Aff,22,61-76.
5. Chiang, TL(1997).Taiwan's 1995 health care reform.Health Policy,39,225-39.
6. Chien, IC,Kuo, CC,Bih, SH(2007).The prevalence and incidence of treated major depressive disorder among National Health Insurance enrollees in Taiwan, 1996 to 2003.Can J Psychiatry,52,28-36.
7. Cipriani A,Brambilla P,Furukawa T(2005).Fluoxetine versus other types of pharmacotherapy for depression.Cochrane Database Syst Rev,2005(2)
8. Development Center for Biotechnology(2002).Yearbook of Pharmaceutical Industry 2002.Taipei:Development Center for Biotechnology.
9. Development Center for Biotechnology(1997).Yearbook of Pharmaceutical Industry 1997.Taipei:Development Center for Biotechnology.
10. Development Center for Biotechnology(2003).Yearbook of Pharmaceutical Industry 2003.Taipei:Development Center for Biotechnology.
11. Development Center for Biotechnology(1999).Yearbook of Pharmaceutical Industry 1999.Taipei:Development Center for Biotechnology.
12. Development Center for Biotechnology(2000).Yearbook of Pharmaceutical Industry 2000.Taipei:Development Center for Biotechnology.
13. Development Center for Biotechnology(2004).Yearbook of Pharmaceutical Industry 2004.Taipei:Development Center for Biotechnology.
14. Development Center for Biotechnology(1998).Yearbook of Pharmaceutical Industry 1998.Taipei:Development Center for Biotechnology.
15. Development Center for Biotechnology(2001).Yearbook of Pharmaceutical Industry 2001.Taipei:Development Center for Biotechnology.
16. Geddes JR,Freemantle N,Mason J,Eccles MP,Boynton J(2000).SSRIs versus other antidepressants for depressive disorder.Cochrane Database Syst Rev
17. Georg, Hsu LK,Wan, YM,Chang, H,Summergrad, P,Tsang, BY,Chen, H(2008).Stigma of depression is more severe in Chinese Americans than Caucasian Americans.Psychiatry,71,210-8.
18. Grant, RM(2002).Contemporary Strategy Analysis.Taipei:Sci-Tech.
19. Guaiana G,Barbui C,Hotopf M(2007).Amitriptyline for depression (review).Cochrane Database Syst Rev
20. Kanter, JW,Rusch, LC,Brondino, MJ(2008).Depression self-stigma: a new measure and preliminary findings.J Nerv Ment Dis,196,663-70.
21. Lacy, CF,Armstrong, LL,Goldman, MP,Lance, LL(2007).Drug Information Handbook.Hudson:Lexu-Comp.
22. Lee, YC,Yang, MC,Huang, YT,Liu, CH,Chen, SB(2006).Impacts of cost containment strategies on pharmaceutical expenditures of the national health insurance in Taiwan, 1996-2003.Pharmacoeconomics,24,891-902.
23. Li, ZJ(2007).Taipei,National Taiwan University.
24. Lichtenberg, FR(2001).Are the benefits of newer drugs worth their cost? Evidence from the 1996 MEPS.Health Aff,20,241-51.
25. Lin, TL,Yang, YH Kao,Tang, CH,Wu, HM,Cheng, HW(2007).Impact of introduction of angiotensin II antagonist on the antihypertensive utilization in Taiwan.J Food Drug Analy,16,21-9.
26. Liu, YM,Kao, YH,Hsieh, CR(2009).Financial incentives and physicians' prescription decisions on the choice between brand-name and generic drugs: evidence from Taiwan.J Health Econ,28,341-9.
27. Preskorn, S(1997).Pharmacotherapeutic profile of venlafaxine.Eur Psychiatry,12(suppl. 4),285s-94s.
28. Sussman, N.,Stahl, S.(1996).Update in the pharmacotherapy of depression.Am J Med,101(suppl. 6A),26S-36S.
29. Trindade, E,Menon, D,Trpfer, LA,Coloma, C(1998).Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis.CMAJ,159,1245-52.
30. Wilson, BA,Shannon, MT,Shields, KM,Stang, CL(2008).Prentice Hall Nurse's Drug Guide.Taipei:Pearson.
31. World Health Organization(2001).The World Health Report 2001.Geneva:World Health Organization.

1. 簡戊鑑,鍾其祥,葉慧雯,葉啟斌,葉奕緯,黃三原,曾念生,張勳安,高譽誠,高廉程,周雨青,江瑋珊(2018).The Newly Diagnosed Amnestic Disorders and Dementia: A Nationwide, Cohort Study in Taiwan.臺灣精神醫學,32(1),18-28+i.